Intrinsic Value

The intrinsic value of Ypsomed Holding AG (OWX) under the Base Case is 415.28 EUR per share. Compared with the current market price of 476.2 EUR, the stock appears Overvalued by 13% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

OWX Intrinsic Value
€415.28
Overvaluation 13%
Intrinsic Value
Price €476.2
Alert me when OWX is below its intrinsic value
Today €332.22 · 30.2% below the current price

OWX is more expensive than usual. It was this expensive or more expensive on just 9% of days in the past 5 years.

Alternatives to OWX

Fundamental Analysis

What Ypsomed Does

Health Care

Ypsomed Holding AG makes drug delivery devices that help patients inject medicines at home. Its core products include insulin pens, pen needles, autoinjectors, and pump systems for people who need regular injections, especially diabetes patients and other chronic-care users. The company also develops and sells connected devices and digital tools that help patients track treatment and use their medicines correctly.

Headquarters
Switzerland CH
Employees
2 025
IPO date
Sep 22, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ypsomed Holding AG

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

YPSN Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OWX stock?

The intrinsic value for Ypsomed Holding AG (OWX) under the Base Case is 415.28 EUR.

Is OWX stock undervalued or overvalued?

Compared with the current market price of 476.2 EUR, the stock appears Overvalued by 13% .

Back to Top